Gestational trophoblastic disease (GTD) is a group of rare tumors that involve abnormal growth of cells inside a woman’s uterus.
What are gestational trophoblastic tumors?
Gestational trophoblastic tumors start in the cells that would normally develop into the placenta during pregnancy. Most GTDs are not cancerous and don’t invade deeply into body tissues or spread to other parts of the body; however, some may be cancerous and require treatment.
Who develops gestational trophoblastic tumors?
Gestational trophoblastic tumors affect women in their childbearing years.
What are the symptoms of gestational trophoblastic tumors?
Symptoms of gestational trophoblastic tumors may include vaginal bleeding during pregnancy (especially during the first three months), abnormal uterine growth and nausea and vomiting.
How are gestational trophoblastic tumors diagnosed?
If you have symptoms, your physician will perform a pelvic exam to feel for abnormal uterine shape or size. He or she will also order an ultrasound and a blood test to look for high levels of a hormone called beta-HCG, which is present during normal pregnancy.
How are gestational trophoblastic tumors treated?
Surgery, called a dilatation and curettage (D&C), is the mainstay of treatment. When these tumors are determined to be malignant, chemotherapy is used as well.
Valley offers comprehensive gynecologic cancer treatment through its gynecologic oncology program. For more information, call 201-634-5401.